Clinical outcome of patients with metastatic melanoma of unknown primary in the era of novel therapy

D. Verver*, D.J. Grunhagen, A.C.J. van Akkooi, M.J.B. Aarts, F.W.P.J. van den Berkmortel, A.J.M. van den Eertwegh, J.W.B. de Groot, M.J. Boers-Sonderen, J.B.A.G. Haanen, G.A.P. Hospers, E. Kapiteijn, D. Piersma, R.S. van Rijn, K.P.M. Suijkerbuijk, A.J. ten Tije, G. Vreugdenhil, C. Verhoef, A.A.M. van der Veldt

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)3123-3135
Number of pages13
JournalCancer Immunology Immunotherapy
Issue number11
Early online date27 Mar 2021
Publication statusPublished - Nov 2021


  • Melanoma
  • Unknown primary
  • Known primary
  • Novel therapy

Cite this